Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

7,889 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Neurocognitive and emotional status after one-year of mindfulness-based intervention in patients with relapsing-remitting multiple sclerosis.
De la Torre GG, Mato I, Doval S, Espinosa R, Moya M, Cantero R, Gonzalez M, Gonzalez C, Garcia MA, Hermans G, González-Torre S, Mestre JM, Hidalgo V. De la Torre GG, et al. Among authors: gonzalez torre s, gonzalez m, gonzalez c. Appl Neuropsychol Adult. 2022 Mar-Apr;29(2):183-192. doi: 10.1080/23279095.2020.1732388. Epub 2020 Mar 9. Appl Neuropsychol Adult. 2022. PMID: 32149525
Predicting Neuropsychological Impairment in Relapsing Remitting Multiple Sclerosis: The Role of Clinical Measures, Treatment, and Neuropsychiatry Symptoms.
Lozano-Soto E, Cruz-López ÁJ, Gutiérrez R, González M, Sanmartino F, Rashid-Lopez R, Espinosa-Rosso R, Forero L, González-Rosa JJ. Lozano-Soto E, et al. Among authors: gonzalez rosa jj, gonzalez m. Arch Clin Neuropsychol. 2021 May 21;36(4):475-484. doi: 10.1093/arclin/acaa088. Arch Clin Neuropsychol. 2021. PMID: 33067616
Erratum to: Predicting Neuropsychological Impairment in Relapsing Remitting Multiple Sclerosis: The Role of Clinical Measures, Treatment, and Neuropsychiatry Symptoms.
Lozano-Soto E, Cruz-Gómez ÁJ, Gutiérrez R, González M, Sanmartino F, Rashid-Lopez R, Espinosa-Rosso R, Forero L, González-Rosa JJ. Lozano-Soto E, et al. Among authors: gonzalez rosa jj, gonzalez m. Arch Clin Neuropsychol. 2021 Aug 31;36(6):1019. doi: 10.1093/arclin/acab063. Arch Clin Neuropsychol. 2021. PMID: 34259311 Free article. No abstract available.
Ibrutinib followed by ofatumumab consolidation in previously untreated patients with chronic lymphocytic leukemia (CLL): GELLC-7 trial from the Spanish group of CLL (GELLC).
Abrisqueta P, González-Barca E, Ferrà C, Ríos-Herranz E, Fernández de la Mata M, Delgado J, Andreu R, Hernández-Rivas JÁ, Terol MJ, Navarro A, Vidriales MB, Baltasar P, De la Serna J, Ramírez Á, Ballester C, Moreno C, García-Marco JA, Córdoba R, Yáñez L, Casado LF, González M, Bosch F. Abrisqueta P, et al. Among authors: gonzalez m. EClinicalMedicine. 2024 May 25;73:102642. doi: 10.1016/j.eclinm.2024.102642. eCollection 2024 Jul. EClinicalMedicine. 2024. PMID: 38841711 Free PMC article.
Epithelial hypoxia maintains colonization resistance against Candida albicans.
Savage HP, Bays DJ, Tiffany CR, Gonzalez MAF, Bejarano EJ, Carvalho TP, Luo Z, Masson HLP, Nguyen H, Santos RL, Reagan KL, Thompson GR, Bäumler AJ. Savage HP, et al. Among authors: gonzalez maf. Cell Host Microbe. 2024 Jun 1:S1931-3128(24)00180-X. doi: 10.1016/j.chom.2024.05.008. Online ahead of print. Cell Host Microbe. 2024. PMID: 38838675
7,889 results